CAS 668467-91-2
:1H-Indole-2,3-dione, 5-chloro-1-[(2,5-dichlorophenyl)methyl]-,3-(O-acetyloxime)
LDN-57444
CAS:LDN-57444 is a reversible, competitive proteasome Uch-L1 inhibitor(IC50=0.88 μM) .Formula:C17H11Cl3N2O3Purity:97.8% - 99.96%Color and Shape:Yellow SolidMolecular weight:397.64LDN-57444
CAS:3-(Acetoxyimino)-5-chloro-1-(2,5-dichlorobenzyl)indolin-2-oneFormula:C17H11Cl3N2O3Purity:98%Molecular weight:397.643-(Acetoxyimino)-5-chloro-1-(2,5-dichlorobenzyl)indolin-2-one
CAS:Purity:98%Molecular weight:397.6400146LDN-57444
CAS:LDN-57444 is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) and inhibits its activation. LDN-57444 is being developed for the treatment of squamous cell carcinoma, which is a type of skin cancer. The drug has been shown to inhibit tumor growth in animal models by inhibiting body formation, promoting autophagy, and reducing mitochondrial membrane potential. LDN-57444 has also been shown to inhibit the proliferation of human cancer cells in vitro and decrease cardiac arrhythmias. LDN-57444 binds to EGFR with a hydroxyl group on its structure that interacts with the EGFR's active site. This binding prevents EGFR from activating downstream signaling pathways, such as those involving phosphatidylinositol 3-kinase (PI3K) and Akt kinase, which are involved in cell proliferation and survival.
Formula:C17H11Cl3N2O3Purity:Min. 95%Molecular weight:397.64 g/mol






